Search

Author/Creator Iannuzzo, G

1. Changes in markers of subclinical atherosclerosis in patients with familial hypercholesterolemia treated with evolocumab: a prospective cohort study. (25th November 2020)

Authors:
Calcaterra, I; Di Minno, A; Gentile, M; Tripaldella, M; Buonaiuto, A; Forte, F; Di Taranto, M.D; Giacobbe, C; Iannuzzo, G; Rubba, P.O.F; Di Minno, M.N.D
Journal:
European heart journal
Issue:
Volume 41:(2020)Supplement 2
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Correlation between different LDL-R mutations and response to ab-PCSK9 therapy in a group of patient with genetic diagnosis of Familial Hypercholesterolemia. Preliminary report. (25th November 2020)

Authors:
Buonaiuto, A; Gentile, M; Calcaterra, I.L; Giacobbe, C; Tripaldella, M; Forte, F; Iannuzzo, G; Di Minno, M.N.D; Fortunato, G; Rubba, P.O.F
Journal:
European heart journal
Issue:
Volume 41:(2020)Supplement 2
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. PCSK9 inhibitors: effectiveness of treatment and changes in background lipid-lowering therapy in a real world Italian population. The AT-TARGET-IT study. (3rd October 2022)

Authors:
Perrone-Filardi, P; Basile, C; Asile, G; Abbate, C; Catalano, A; Merlini, P A; Calabro', P; Iannuzzo, G; Ciccone, M M; Paloscia, L; Varbella, F; Brunetti, N D; Indolfi, C; Paolillo, S; Gargiulo, P
Journal:
European heart journal
Issue:
Volume 43(2022)Supplement 2
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗